Home
Heidi Grundt's picture

Heidi Grundt

Associate Professor
  • E-mailHeidi.Grundt@uib.no
  • Phone+47 51 51 80 00
  • Visitor Address
    Haukeland universitetssykehus, Laboratoriebygget
  • Postal Address
    Postboks 7804
    5020 Bergen
Academic article
  • 2017. Vitamin D Uptake in Patients Treated with a High-Dosed Purified Omega-3 Compound in a Randomized Clinical Trial Following an Acute Myocardial Infarction. Frontiers in Cardiovascular Medicine. 6 pages.
  • 2017. The prognostic utility of dihomo-gamma-linolenic acid (DGLA) in patients with acute coronary heart disease. International Journal of Cardiology. 12-17.
  • 2016. Suggested Cut-Off Values for Vitamin D as a Risk Marker for Total and Cardiac Death in Patients with Suspected Acute Coronary Syndrome. Frontiers in Cardiovascular Medicine. 7 pages.
  • 2016. Long-term prognostic utility of pentraxin 3 and D-dimer as compared to high-sensitivity C-reactive protein and B-type natriuretic peptide in suspected acute coronary syndrome. European Journal of Preventive Cardiology. 1130-1140.
  • 2015. Prognostic utility of vitamin D in acute coronary syndrome patients in coastal Norway. Disease Markers. 11 pages.
  • 2015. Borderline values of troponin-T and high sensitivity C-reactive protein did not predict 2-year mortality inTnT positive chest-pain patients, whereas brain natriuretic peptide did. Frontiers in Cardiovascular Medicine. 1-10.
  • 2014. Re-admissions to hospital and patient satisfaction among patients with chronic obstructive pulmonary disease after telemedicine video consultation - A retrospective pilot study. Multidisciplinary Respiratory Medicine. 8 pages.
  • 2013. Long-term prognostic utility of PAPP-A and calprotectin in suspected acute coronary syndrome. Scandinavian Cardiovascular Journal. 88-97.
  • 2011. B-type natriuretic peptide and high sensitive C-reactive protein predict 2-year all cause mortality in chest pain patients: a prospective observational study from Salta, Argentina. BMC Cardiovascular Disorders. 11 pages.
  • 2010. A history of late and very late stent thrombosis is not associated with increased activation of the contact system, a case control study. Thrombosis Journal. 6.
  • 2009. The long pentraxin 3 (PTX3): a novel prognostic inflammatory marker for mortality in acute chest pain. Thrombosis and Haemostasis. 555-563.
  • 2009. Activated factor XII type A predicts long-term mortality in patients admitted with chest pain. Journal of Thrombosis and Haemostasis. 277-287.
  • 2009. Activated factor XII type A and B-type natriuretic peptide are complementary and incremental predictors of mortality in patients following admission with acute coronary syndrome. Blood Coagulation and Fibrinolysis. 652-660.
  • 2009. (n-3) Fatty Acid Content of Red Blood Cells Does Not Predict Risk of Future Cardiovascular Events following an Acute Coronary Syndrome. Journal of Nutrition. 507-513.
  • 2008. The prognostic utility of D-dimer and fibrin monomer at long-term follow-up after hospitalization with coronary chest pain. Blood Coagulation and Fibrinolysis. 701-707.
  • 2008. The long-term prognostic value of multiple biomarkers following a myocardial infarction. Thrombosis Research. 60-66.
  • 2008. Low levels of cellular omega-3 increase the risk of ventricular fibrillation during the acute ischaemic phase of a myocardial infarction. Resuscitation. 258-264.
  • 2008. Holotranscobalamin and methylmalonic acid as prognostic markers following an acute myocardial infarction. European Journal of Clinical Nutrition. 411-418.
  • 2008. B-type natriuretic peptide is a long-term predictor of all-cause mortality, whereas high-sensitive C-reactive protein predicts recurrent short-term troponin T positive cardiac events in chest pain patients: a prognostic study. BMC Cardiovascular Disorders.
  • 2008. Activated Factor XII Type A Predicts Long-Term Mortality in Patients Admitted with Chest Pain. Journal of Thrombosis and Haemostasis. 277-287.
  • 2007. The effect of primary percutaneous coronary intervention as compared to tenecteplase on myeloperoxidase, pregnancy-associated plasma protein A, soluble fibrin and D-dimer in acute myocardial infarction. Thrombosis Research. 415-421.
  • 2007. Homocysteine-lowering therapy does not affect inflammatory markers of atherosclerosis in patients with stable coronary artery disease. Journal of Internal Medicine. 244-253.
  • 2007. Changes of plasma activated Factor XII type A (XIIaA) concentrations following percutaneous coronary intervention (PCI). Journal of Thrombosis and Thrombolysis. 131-135.
  • 2006. Specific types of activated Factor XII increase following thrombolytic therapy with tenecteplase. Journal of Thrombosis and Thrombolysis. 199-203.
  • 2006. Long term influence of regular intake of high dose n-3 fatty acids on CD40-ligand, pregnancy-associated plasma protein A and matrix metal loproteinase-9 following acute myocardial infarction. Thrombosis and Haemostasis. 329-336.
  • 2004. Interaksjon mellom hjerte- og lungesykdom. Hjerteforum. 40-46.
  • 2004. Interaksjon mellom hjerte- og lungesykdom. Lungeforum. 25-31.
  • 2004. Clinical outcome and atherothrombogenic risk profile after prolonged wash-out following long-term treatment with high doses of n-3 PUFAs in patients with an acute myocardial infarction. Clinical Nutrition. 491-500.
  • 2004. Activated factor 12 (FXIIa) predicts recurrent coronary events after an acute myocardial infarction. American Heart Journal. 260-266.
  • 1999. Atherothrombogenic risk modulation by n-3 fatty acids was not associated with changes in homocysteine in subjects with combined hyperlipidaemia. Thrombosis and Haemostasis. 561-565.
Academic lecture
  • 2016. The Prognostic Utility of Vitamin D Across Continents in Patients with Suspected Acute Coronary Syndrome. Circulation. 2016; 133: AP028.
  • 2013. Seasonal Discrepancy in the Correlation between Vitamin D and Omega-3 Index in Patients With Acute Coronary Syndrome from Western Norway. Circulation 2013; 128: A13208.
  • 2012. Circulation 2012;126:A13464(oral). Pentraxin 3 is Uninfluenced by High Doses of Concentrated Omega-3 Fatty Acids Administered for 12 Months Following an Acute Myocardial Infarction.
  • 2011. Vitamin D Status is a 2-Year Predictor of All-Cause Mortality and Cardiac Death in Chest Pain Patients: A Prognostic Study from Salta, Northern-Argentina. Circulation 2011; 124(21): Supplement. Abstract 10377.
  • 2010. Circulation. 2010;122:A10837. Abstract 10837: Brain Natriuretic Peptide, but Not Calprotectin or the Long Pentraxin 3 Independently Predicts Stroke in Long-Term Follow-up of Patients With Acute Coronary Syndrome.
  • 2007. The prognostic value of NT-proBNP versus PAPP-A, MPO and CD40L following a myocardial infarction. European Heart Journal 2007;Vol.28 (Abstract Supplement):265: abstract 1699.
  • 2006. Changes In Activated Factor XII From Admission To Day 4 Strongly Predict Recurrent Troponin-T Positive Cardiac Events At 30 Days Following Admission For Myocardial InfarctionPathophysiol Haemos Thromb2006; 35:199-248.
  • 2006. B-Type Natriuretic peptide is a predictor of all cause mortality at long-term follow-up after hospitalization with acute chest painEur Heart J 2006, 27(Abstract Suppl), 570.
  • 2006. Activated Factor XII type A strongly predicts all cause mortality after hospitalisation with TnT negative chest painEur Heart J 2006, 27(Abstract Suppl), 878.
  • 2006. Activated Factor XII Type A Strongly Predicts All Cause Mortality after Hospitalisation with Chest Pain.AACC Annual Meeting, 2006, Chicago, Abstract nr. D52.
  • 2005. Activated factor XII type A strongly predicts all cause mortality after hospitalisation with TnT negative chest pain. Circulation 2005;112(17):Suppl.II:p388,abstract 1903.
  • 2005. Activated factor XII provides better short-term prognostic information for a subsequent troponin-T positive event than other biomarkers in patients with myocardial infarction. J Thromb Haemost 2005;3:Suppl.1, OR155. ISSN:1740-3340.
Editorial
  • 2008. n-3 fatty acids and cardiovascular disease. Haematologica. 807-812.
Doctoral dissertation
  • 2004. Risk evaluation in atherothrombogenic populations receiving a high dose of n-3 fatty acids, with special reference to homocysteine, tissue factor, activated factor XII and peroxidation.
Abstract
  • 2013. THE LONG PENTRAXIN 3 DID NOT PREDICT OUTCOME WITHIN 45 MONTHS FOLLOW-UP IN PATIENTS FOLLOWING A SEVERE MYOCARDIAL INFARCTION. Journal of the American College of Cardiology. E185-E185.
  • 2012. Long Pentraxin 3 (PTX3), Activated Factor XII type A (XIIaA) and B-type Natriuretic Peptide (BNP) did not independently predict stroke during seven years follow-up in patients admitted with chest pain. European Heart Journal. 236-236.
  • 2012. BNP, PTX3, and D-dimer are predictors of death, but only BNP is also a predictor of troponin-T positive cardiac events at long-term follow-up after hospitalization with acute chest pain. European Heart Journal. 947-947.
  • 2012. Activated factor XII type A independently predicts outcome during seven years follow-up in patients admitted with suspected acute coronary syndrome. European Heart Journal. 444-444.
  • 2010. A combination of novel biomarkers for coagulation (XIIaA), vascular inflammation (PTX3) and heart failure (BNP) enhances prognostic information in patients admitted with chest pain. European Heart Journal. 803-803.
  • 2008. Comparison of the omega-3 index in the acute coronary syndromes in a beef-eating population in Argentina as compared to a fish-eating population in Norway. Circulation. E439-E439.
  • 2008. Activated Factor XII type A is an independent predictor of cardiovascular outcome in coronary patients admitted with troponin T negative chest pain. Circulation. E194-E195.
  • 2008. Activated Factor XII and B-type natriuretic peptide, but not C-reactive protein, are independent predictors of mortality following admission with suspected myocardial infarction. Circulation. E194-E194.
  • 2005. B-Type Natriuretic peptide is not only a predictor of death, but also of troponin-T positive cardiac events at 6 months follow-up after hospitalisation with acute chest pain. European Heart Journal. 717-717.
  • 2004. Activated factor XII predicts troponin-T positive cardiac events at 30 days follow-up after hospitalization with acute chest pain. Circulation.
Poster
  • 2017. Circulation 2017;136:A18301 The Prognostic Utility of Dihomo-gamma-linolenic Acid (dgla) in Patients With Acute Coronary Heart Disease.
  • 2016. Global Heart, Vol. 11, Issue 2, e96–e97 Published in issue: June 2016 PM149 Activated End-Stage Coagulation (D-Dimer and Fibrin Monomer) but not Initial Stage (Fxiia) is Associated with the Burden of Thromboatheromatosis in Patients with Acute Coronary Syndrome.
  • 2016. Global Heart, Vol. 11, Issue 2, e160. PT215 Novel Inflammatory Biomarkers Including Pentraxin-3 (PTX3), Pregnancy Associated Plasma Protein-A (PAPP-A) and Calprotectin were not Associated With the Burden of Thromboatheromatosis in Patients With Acute Coronary Syndrome.
  • 2014. The Effect on Vitamin D Levels of Long-term High-dose Treatment With a Concentrated Omega-3 Compound (Omacor®/Lovaza®) in Patients Hospitalized With a Myocardial Infarction. Core 2. Epidemiology and Prevention of CV Disease: Physiology, Pharmacology and LifestyleSession Title: Nutrition in CVD Risk and Prevention I. Circulation. 2014; 130: A17245.
  • 2014. BNP, PTX3 AND D-DIMER ARE LONG-TERM PREDICTORS OF MORTALITY IN CHEST PAIN PATIENTS – BNP AND HSCRP ALSO PREDICTS MYOCARDIAL INFARCTION. Atherosclerosis 2014; 235: e84–e191 (Abstract e142).
  • 2012. Circulation 2012;125(10)Suppl:AP325. The Prognostic Utility of Vitamin D and Its Seasonal Variation in Chest Pain Patients with Suspected Acute Coronary Syndrome Recruited from a Coastal Population in Western-Norway.
  • 2012. Circulation 2012;125(10)Suppl:AP310. The Distribution of Total- and HDL Cholesterol and Triglycerides is Significantly Different across Quartiles of Vitamin D in Chest-Pain Patients with a Suspected Acute Coronary Syndrome.
  • 2011. The predictive value of the long pentraxin 3 (PTX3) for heart failure development in acute chest pain patients. Journal of Thrombosis and Haemostasis 2011; 9: Supplement s2, P-MO-567. Article first published online: 31 JUL 2011.
  • 2011. The long pentraxin 3 (PTX3), a biomarker of inflammation, predicts long-term mortality in patients hospitalized with suspected acute coronary syndrome. Journal of Thrombosis and Haemostasis 2011; 9: Supplement s2,P-WE-146. Article first published online: 31 JUL 2011.
  • 2011. The long pentraxin 3 (PTX3), a biomarker of inflammation, predicts long-term mortality in patients hospitalized with suspected acute coronary syndrome. Journal of Thrombosis and Haemostasis 2011; 9, Issue Supplement s2, P-MO-556. Article first published online: 31 JUL 2011.
  • 2011. D-dimer is an independent predictor of mortality at long-term follow-up in patients with suspected acute coronary syndrome. Journal of Thrombosis and Haemostasis 2011; 9: Supplement s2, P-TU-422. Article first published online: 31 JUL 2011.
  • 2011. Admission level of pregnancy-associated plasma protein a predicts long term mortality within 7 years follow up in patients admitted with suspected acute coronary syndrome. Journal of Thrombosis and Haemostasis 2011; 9: Supplement s2, P-WE-596. Article first published online: 31 JUL 2011.
  • 2010. European Heart Journal 2010; 31 (Abstract Supplement): 803. P4661 : A combination of novel biomarkers for coagulation (XIIaA), vascular inflammation (PTX3) and heart failure (BNP) enhances prognostic information in patients admitted with chest pain.
  • 2009. Would the use of N-terminal pro-B-type natriuretic peptide as a prognostic marker have changed our clinical judgement? Journal of Thrombosis and Haemostasis 2009; Volume 7, Supplement 2: Abstract PP-WE-830.
  • 2009. The value of d-dimer and fibrin monomer as prognostic markers of death at 30 days follow-up in chest pain patients with suspected acute coronary syndrome. Journal of Thrombosis and Haemostasis 2009; Volume 7, Supplement 2: Abstract PP-WE-829.
  • 2009. The value of calprotectin as a prognostic marker of cardiovascular risk in acute chest pain. European Heart Journal (2009)30(Abstract Supplement),472.
  • 2009. The relationship between the long pentraxin 3 and B-type natriuretic peptide in patients admitted with acute coronary syndromes. European Heart Journal (2009)30 (Abstract Supplement),135.
  • 2009. The plasma kallikrein-kinin system and clinical outcome during follow-up in chest-pain-patients. Journal of Thrombosis and Haemostasis 2009; Volume 7, Supplement 2: Abstract PP-TH-131.
  • 2009. The correlation of the long pentraxin 3 (PTX3) to lipids in patients hospitalized with acute chest pain. European Heart Journal (2009)30(Abstract Supplement),374.
  • 2009. Evaluation of plaque destabilization by pregnancy-associated plasma protein a (PAPPA) and coagulant activity did not predict reccurent Troponin-T positive cardiac events following an acute myocardial infarction. Journal of Thrombosis and Haemostasis 2009; Volume 7, Supplement 2: Abstract PP-WE-831.
  • 2009. Changes of inhibitory complexes of the plasma kallikrein-kinin system following percutaneous coronary intervention or thrombolytic therapy with tenecteplase. Journal of Thrombosis and Haemostasis 2009; Volume 7, Supplement 2: Abstract PP-WE-126.
  • 2009. A history of late stent thrombosis is not associated with increased activation of the contact phase system. Journal of Thrombosis and Haemostasis 2009; Volume 7, Supplement 2: Abstract PP-MO-433.
  • 2008. The Prognostic Value of the Long Pentraxin 3 as Compared to B-Type Natriuretic Peptide and High-Sensitive C-Reactive Protein, and their Combination, as a Prognostic Marker of Mortality in Acute Chest Pain Patients. Circulation. 2008; 118(18): Suppl., Abstract 576.
  • 2008. Long Pentraxin 3: A New, Independent Marker of Mortality in Acute Chest Pain. Circulation. 2008; 118(18): Suppl., Abstract 577.
  • 2007. Omega-3 Index: A risk factor for ventricular fibrillation in the early post-myocardial inarction phase. 47th Annual Conference Cardiovascular disease Epidemiology and Prevention in association with the Council on Nutrition, Physical Activity, and Metabolism, Orlando, Florida. Circulation 2007; 115(8); e214-e301: e-237, Abstract P69. Print ISSN: 0009-7322. Online ISSN: 1524-4539.
  • 2007. NT-proBNP, and not TF, FM; PAPPA-A or CD40 Ligand, predicts recurrent troponin-T positive cardiac events following an acute myocardial infarction. J Thromb Haemost 2007; Abstract ISTH 07A1_P-M-585.
  • 2007. Changes in activated factor XII type A from admission to Day 4 predict recurrent troponin T positive cardiac events following admission for myocardial infarction. Arterioscl Thromb Vasc Biol 2007; 27; e35-e137: e80, P243. Print ISSN: 1079-5642. Online ISSN: 1524-4636.
  • 2007. Cardiac omega-3 content and risk of future cardiovascular events following an acute coronary syndrome. European Heart Journal 2007;Vol.28 (Abstract Supplement):265: P3561.
  • 2007. Activated factor XII type A is an independent predictor of all-cause mortality in patients admitted with chest pain. Arterioscl Thromb Vasc Biol 2007; 27; e35-e137: e128, P519. Print ISSN: 1079-5642. Online ISSN: 1524-4636.
  • 2007. Activated factor XII type A independently predicts 12 month mortality in chest pain patients. J Thromb Haemost 2007; Abstract ISTH 07A1_P-W-009.
  • 2007. Activated Factor XII Type A predicts cardiovascular outcome in patients admitted with chest pain. European Heart Journal 2007;Vol.28 (Abstract Supplement):113.
  • 2006. No protection against new cardiac events of a high Omega-3 Index in patients presenting with an acute coronary syndrome.Circulation 2006:114(18) (Suppl II): abstr 4176.
  • 2006. No prognostic value of holo-transcobalamin or methylmalonic acid following an acute myocardial infarction.Circulation 2006; 113: e301-e381, abstrakt nummer P325.
  • 2006. No effect of omega-3 versus corn oil intervention on Pregnancy-Associated Plasma Protein A (PAPP-A) and CD-40 Ligand following an acute myocardial infarction.Circulation 2006; 113: e301-e381, abstrakt nummer P315.
  • 2006. No Protection of a High Omega-3 Index Following an Acute Myocardial Infarction.Atherosclerosis 2006; 7 (3): Suppl. pp 449.
  • 2005. Specific forms of activated factor XII in citrated plasma increase following percutaneous coronary intervention (PCI). J Thromb Haemost 2005;3:Suppl.1, P1736. ISSN:1740-3340.
  • 2005. Low fibrin monomer (soluble fibrin)concentration predicts troponin-T positive cardiac event free survival at 30 days follow-up after hospitalization with acute chest pain. JACC 2005;45:Supplement A, Abstract 1068-109.
  • 2005. Changes in concentration of specific forms of activated factor XII are observed following thrombolytic therapy with tenecteplase. J Thromb Haemost 2005;3:Suppl.1,P1615.ISSN: 1740-3340.
  • 2005. B-type Natriuretic Peptide is not only a predictor of death, but also of troponin-T positive cardiac events at long-term follow-up after hospitalization with acute chest pain. Circulation 2005; 112(17):Suppl.II:p 319, abstract 1600.
  • 2005. B-Type Natriuretic peptide is not only a predictor of death, but also of troponin-T positive cardiac events at 6 months follow-up after hospitalisation with acute chest pain. Eur Heart J 2005;26 Abstract Supplement;717 (P4064).
  • 2004. Inflammatory Markers CD40L, IL-6, Neopterin and CRP are Not Influenced by Homocysteine Lowering Therapy in Patients with Coronary Artery Disease.
  • 2000. Influence on inflammatory markers of high-dose n-3 fatty acids after one year of treatment following an acute myocardial infarction.
Academic literature review
  • 2012. The Role of Long-Chained Marine N-3 Polyunsaturated Fatty Acids in Cardiovascular Disease. 15 pages.

More information in national current research information system (CRIStin)